ES2318119T3 - Procedimiento y composiciones para alterar el perfil del efecto edulcorante de la sucralosa. - Google Patents

Procedimiento y composiciones para alterar el perfil del efecto edulcorante de la sucralosa. Download PDF

Info

Publication number
ES2318119T3
ES2318119T3 ES03714505T ES03714505T ES2318119T3 ES 2318119 T3 ES2318119 T3 ES 2318119T3 ES 03714505 T ES03714505 T ES 03714505T ES 03714505 T ES03714505 T ES 03714505T ES 2318119 T3 ES2318119 T3 ES 2318119T3
Authority
ES
Spain
Prior art keywords
compositions
profile
sucralosa
alter
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03714505T
Other languages
English (en)
Inventor
Carolyn M Merkel
Steven J Catani
John C Fry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tate and Lyle Technology Ltd
Original Assignee
Tate and Lyle Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tate and Lyle Technology Ltd filed Critical Tate and Lyle Technology Ltd
Application granted granted Critical
Publication of ES2318119T3 publication Critical patent/ES2318119T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/60—Sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/37—Halogenated sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Una composición que comprende 4,1'',6''-tricloro-4,1'',6''-tridesoxigalactosacarosa en una cantidad de aproximadamente el 98,0% al 99,999% de dicha composición en peso, al menos un derivado de azúcar halogenado de la siguiente fórmula (I), y al menos un derivado de azúcar halogenado seleccionado entre el grupo de las siguientes fórmulas (II-III):** ver fórmula** en la que R1 representa un grupo hidroxi, un grupo acilo, o un átomo de halógeno; R2 y R3 representan, respectivamente: (a) un átomo de hidrógeno y un grupo hidroxi; (b) un hidrógeno y un átomo de halógeno; (c) un átomo de halógeno y un átomo de hidrógeno; o (d) un grupo hidroxi y un átomo de hidrógeno; R4, R5, R6, R7, R8, R9 y R10 representan un átomo de hidrógeno, un grupo hidroxi, o un átomo de halógeno; y ** ver fórmula** en la que R1 representa un grupo hidroxi, un grupo acilo, o un átomo de halógeno; R2 y R3 representan, respectivamente: (a) un átomo de hidrógeno y un grupo hidroxi; (b) un hidrógeno y un átomo de halógeno; (c) un átomo de halógeno y un átomo de hidrógeno; o (d) un grupo hidroxi y un átomo de hidrógeno; R4, R5, R8, R9 y R10 representan un átomo de hidrógeno, un grupo hidroxi, o un átomo de halógeno; y ** ver fórmula** en la que R1 representa un grupo hidroxi, un grupo acilo, o un átomo de halógeno; R2 y R3 representan, respectivamente: (a) un átomo de hidrógeno y un grupo hidroxi; (b) un hidrógeno y un átomo de halógeno; (c) un átomo de halógeno y un átomo de hidrógeno; o (d) un grupo hidroxi y un átomo de hidrógeno; y R5, R8, y R10 representan un átomo de hidrógeno, un grupo hidroxi, o un átomo de halógeno.
ES03714505T 2002-04-05 2003-04-04 Procedimiento y composiciones para alterar el perfil del efecto edulcorante de la sucralosa. Expired - Lifetime ES2318119T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/116,759 US20040170735A2 (en) 2002-04-05 2002-04-05 Methods and compositions for altering the sweetness delivery profile of sucralose

Publications (1)

Publication Number Publication Date
ES2318119T3 true ES2318119T3 (es) 2009-05-01

Family

ID=28674059

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03714505T Expired - Lifetime ES2318119T3 (es) 2002-04-05 2003-04-04 Procedimiento y composiciones para alterar el perfil del efecto edulcorante de la sucralosa.

Country Status (15)

Country Link
US (1) US20040170735A2 (es)
EP (1) EP1492801B1 (es)
JP (1) JP4395653B2 (es)
KR (1) KR101026157B1 (es)
CN (1) CN1646552A (es)
AT (1) ATE420096T1 (es)
AU (1) AU2003218501C1 (es)
BR (1) BRPI0308992B1 (es)
CA (1) CA2481404C (es)
DE (1) DE60325710D1 (es)
ES (1) ES2318119T3 (es)
IL (1) IL164405A0 (es)
MX (1) MXPA04009719A (es)
RU (1) RU2004132234A (es)
WO (1) WO2003087116A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968138B2 (en) 2004-07-23 2011-06-28 Arnold Nerenberg Food sweetener
GB2417555A (en) * 2004-07-28 2006-03-01 John Charles Fry Sucralose analysis
US8597714B1 (en) 2005-03-17 2013-12-03 Graceland Fruit, Inc. No sugar added dried and dessert fruits and processes for preparing the same
US20060286223A1 (en) * 2005-06-15 2006-12-21 Carol Long Reduced sugar RTE cereals with maltodextrin
CA2613716A1 (en) * 2005-06-27 2007-01-04 Cargill, Incorporated Sugar substitute compositions and use thereof in foods and beverages
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8993027B2 (en) * 2005-11-23 2015-03-31 The Coca-Cola Company Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
EP1965667A2 (en) * 2005-11-23 2008-09-10 The Coca-Cola Company Synthetic sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US9144251B2 (en) * 2005-11-23 2015-09-29 The Coca-Cola Company High-potency sweetener composition with mineral and compositions sweetened therewith
US8575333B2 (en) * 2006-09-14 2013-11-05 Bahram Memarzadeh Halogenated alkyl di- and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
WO2008082596A2 (en) * 2006-12-28 2008-07-10 Cargill, Incorporated Low calorie sweetener compositions
US8029846B2 (en) 2007-03-14 2011-10-04 The Concentrate Manufacturing Company Of Ireland Beverage products
US20080226803A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Natural flavoring agent for sugar-sweetened tea beverage to taste like high fructose corn syrup-sweetened beverage
US8084073B2 (en) 2007-03-14 2011-12-27 Concentrate Manufacturing Company Of Ireland Anisic acid modified steviol glycoside sweetened beverage products
US8277861B2 (en) 2007-03-14 2012-10-02 Concentrate Manufacturing Company Of Ireland Beverage products having steviol glycosides and at least one acid
US20080226800A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Diet cola beverages
US20080226773A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage Sweetened with Rebaudioside A
US9877500B2 (en) 2007-03-14 2018-01-30 Concentrate Manufacturing Company Of Ireland Natural beverage products
US20080226802A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage having natural sweeteners with one or more stevia components and source of berry
US9314048B2 (en) 2007-03-14 2016-04-19 The Concentrate Manufacturing Company Of Ireland Beverage products with non-nutritive sweetener and bitterant
US20080226799A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Diet Cola Beverages
US8277862B2 (en) 2007-03-14 2012-10-02 Concentrate Manufacturing Company Of Ireland Beverage products having steviol glycosides and at least one acid
US20080226798A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Cola Beverages
US20090162487A1 (en) * 2007-12-21 2009-06-25 The Concentrate Manufacturing Company Of Ireland Beverage products and flavor systems having a non-sweetening amount of rebaudioside a
US20090162488A1 (en) * 2007-12-21 2009-06-25 The Concentrate Manufacturing Company Of Ireland Beverage products and flavor systems having a non-sweetening amount of monatin
JP5924906B2 (ja) * 2011-11-10 2016-05-25 ホーユー株式会社 毛髪処理剤組成物及び毛髪処理方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030804B1 (en) * 1979-12-18 1983-10-19 TATE & LYLE PUBLIC LIMITED COMPANY Crystalline 4,1',6'-trichloro-4,1',6'-trideoxy-galactosucrose
DE3062467D1 (en) * 1979-12-20 1983-04-28 Tate & Lyle Plc Process for the preparation of 4,1',6'-trichloro-4,1',6'-trideoxy-galactosucrose
ATE9355T1 (de) * 1980-07-08 1984-09-15 Tate & Lyle Public Limited Company Verfahren zur herstellung von 4,1',6'-trichlor4,1',6'-trideoxygalactosucrose (tgs).
CA1183133A (en) * 1980-10-28 1985-02-26 Tate & Lyle Public Limited Company Sweet chlorine-substituted disaccharides
ATE20567T1 (de) * 1981-04-29 1986-07-15 Tate & Lyle Plc Suessstoffe.
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
PH26074A (en) * 1988-08-09 1992-02-06 Warner Lambert Co Synergistic sweetening composition containing chloro - compositions containing same and a process for the preparation thereof
GB8822674D0 (en) * 1988-09-27 1988-11-02 Tate & Lyle Plc Preparation of acylated sucrose derivatives
US4980463A (en) * 1989-07-18 1990-12-25 Noramco, Inc. Sucrose-6-ester chlorination
US5080910A (en) * 1990-05-15 1992-01-14 Werner-Lambert Company Stabilized chlorodeoxysugar sweetening agents in powder form and methods for preparing same
US5298611A (en) * 1993-03-12 1994-03-29 Mcneil-Ppc, Inc. Sucralose pentaester production
US5530106A (en) * 1993-03-12 1996-06-25 Mcneil-Ppc, Inc. Recovery of sucralose intermediates
US6461658B1 (en) * 1998-07-07 2002-10-08 Mcneil-Ppc, Inc. Method of improving sweetness delivery of sucralose

Also Published As

Publication number Publication date
IL164405A0 (en) 2005-12-18
KR20050011739A (ko) 2005-01-29
US20040170735A2 (en) 2004-09-02
US20030190396A1 (en) 2003-10-09
RU2004132234A (ru) 2005-04-20
KR101026157B1 (ko) 2011-04-05
US20040076728A2 (en) 2004-04-22
AU2003218501C1 (en) 2009-02-19
ATE420096T1 (de) 2009-01-15
AU2003218501A1 (en) 2003-10-27
CA2481404C (en) 2011-05-31
DE60325710D1 (de) 2009-02-26
AU2003218501A2 (en) 2003-10-27
EP1492801B1 (en) 2009-01-07
JP4395653B2 (ja) 2010-01-13
JP2005531299A (ja) 2005-10-20
CN1646552A (zh) 2005-07-27
EP1492801A1 (en) 2005-01-05
MXPA04009719A (es) 2005-07-14
AU2003218501B2 (en) 2008-09-25
BR0308992A (pt) 2005-01-04
BRPI0308992B1 (pt) 2015-03-24
CA2481404A1 (en) 2003-10-23
WO2003087116A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
ES2318119T3 (es) Procedimiento y composiciones para alterar el perfil del efecto edulcorante de la sucralosa.
WO2004041203A3 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
UA85559C2 (en) Aminobenzophenone compounds
DK2207786T3 (da) 2´-Fluor-2´-deoxytetrahydrouridiner som cytidindeaminasehæmmere
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
CY1108808T1 (el) Ενωσεις μοτιλιδης
NO20090596L (no) Antivirale fosfinatforbindelser
MY143677A (en) Amide prodrug of gemcitabine, compositions and use thereof
WO2007092496A3 (en) 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
WO2005009348A3 (en) Substituted purine derivatives
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
CY1112194T1 (el) Μεθοδοι για ρυθμιση φωτοτοξικοτητας
NO20072048L (no) Anvendelse av IL-17F for behandling og/eller forebygging av neurologiske sykdommer.
GB0520872D0 (en) Onion flavour compounds and use
BRPI0410638A (pt) derivados de azitromicina
TW200503675A (en) Combination of phenylcarboxamides with blockers of the Ikr channel and their use for the treatment of atrial arrhythmias
WO2004056762A3 (en) Novel aminobenzophenone compounds
SE0301798D0 (sv) New use IV